| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.40B | 3.88B | 3.94B | 3.78B | 3.61B | 2.91B |
| Gross Profit | 1.58B | 1.50B | 1.59B | 1.31B | 1.31B | 1.05B |
| EBITDA | 797.30M | 902.60M | 976.20M | 933.10M | 844.20M | 594.80M |
| Net Income | 119.10M | 424.00M | 510.20M | 512.00M | 459.10M | 262.80M |
Balance Sheet | ||||||
| Total Assets | 13.80B | 5.23B | 4.91B | 4.48B | 4.24B | 4.09B |
| Cash, Cash Equivalents and Short-Term Investments | 562.20M | 562.70M | 365.00M | 113.00M | 125.00M | 208.50M |
| Total Debt | 4.97B | 1.21B | 1.20B | 1.14B | 955.50M | 922.60M |
| Total Liabilities | 7.41B | 3.07B | 3.05B | 2.87B | 2.91B | 3.03B |
| Stockholders Equity | 6.40B | 2.16B | 1.86B | 1.61B | 1.33B | 1.06B |
Cash Flow | ||||||
| Free Cash Flow | 205.88M | 380.60M | 464.90M | 16.30M | 499.40M | 676.20M |
| Operating Cash Flow | 600.06M | 802.80M | 914.20M | 607.60M | 757.20M | 786.90M |
| Investing Cash Flow | -4.24B | -446.70M | -470.50M | -660.10M | -348.20M | -120.40M |
| Financing Cash Flow | 3.46B | -165.90M | -210.10M | -25.40M | -449.60M | -540.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $39.98B | 38.21 | 12.99% | 0.67% | 6.54% | 32.48% | |
72 Outperform | $40.13B | 36.06 | 10.65% | 0.51% | 1.99% | -41.08% | |
71 Outperform | $18.46B | 18.82 | 3.14% | 0.74% | -6.34% | 210.97% | |
70 Outperform | $6.89B | 16.95 | 28.77% | 0.47% | 1.50% | -4.44% | |
70 Outperform | $78.67B | 21.78 | 15.21% | 1.17% | 4.28% | 0.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | $13.93B | 89.68 | 2.80% | ― | -1.59% | -15.58% |